CD43 promotes cell growth and helps to evade FAS-mediated apoptosis in non-hematopoietic cancer cells lacking the tumor suppressors p53 or ARF

Oncogene

Volumn 27, Issue 12, 2008, Pages 1705-1715

  Kadaja Saarepuu, L ^a   Laos, S ^b   Jaager K ^a   Viil, J ^a   Balikova, A ^a   Looke M ^a   Hansson, G C ^b   Maimets, T ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Colony formation; Epithelial cell; FAS; Leukosialin; Sialophorin

Indexed keywords

ARF PROTEIN; DEATH RECEPTOR; FAS ANTIGEN; LEUKOSIALIN; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; CANCER GROWTH; CELL GROWTH; COLON ADENOMA; COLONY FORMATION; COLORECTAL ADENOMA; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, CD43; ANTIGENS, CD95; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENES, P53; HCT116 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 40749115695     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210802     Document Type: Article

References (50)

1. Abarzua P, LoSardo J, Gubler M, Neri A. (1995). Micro-injection of monoclonal antibody PAb421 into human SW480 colorectal carcinoma cells restores the transcription activation function to mutant p53. Cancer Res 55: 3490-3494.
2. Andersson C, Fernandez-Rodriguez J, Laos S, Sikut R, Sikut A, Baeckstrom D et al. (2004). CD43 has a functional NLS, interacts with beta-catenin, and affects gene expression. Biochem Biophys Res Commun 316: 12-17.
3. Ardman B, Sikorski MA, Staunton DE. (1992). CD43 interferes with T-lymphocyte adhesion. Proc Natl Acad Sci USA 89: 5001-5005.
4. Baeckstrom D, Zhang K, Asker N, Ruetschi U, Ek M, Hansson GC. (1995). Expression of the leukocyte-associated sialoglycoprotein CD43 by a colon carcinoma cell line. J Biol Chem 270: 13688-13692.
5. Bazil V, Brandt J, Chen S, Roeding M, Luens K, Tsukamoto A et al. (1996). A monoclonal antibody recognizing CD43 (leukosialin) initiates apoptosis of human hematopoietic progenitor cells but not stem cells. Blood 87: 1272-1281.
6. Bazil V, Brandt JE, Hoffman R. (1997). Resistance of human hematopoietic stem cells to a monoclonal antibody recognizing CD43. Stem Cells 15: 13-18; discussion 18-19.
7. Brown TJ, Shuford WW, Wang WC, Nadler SG, Bailey TS, Marquardt H et al. (1996). Characterization of a CD43/ leukosialin-mediated pathway for inducing apoptosis in human T-lymphoblastoid cells. J Biol Chem 271: 27686-27695.
8. Carlsson SR, Fukuda M. (1986). Isolation and characterization of leukosialin, a major sialoglycoprotein on human leukocytes. J Biol Chem 261: 12779-12786.
9. Cermak L, Simova S, Pintzas A, Horejsi V, Andera L. (2002). Molecular mechanisms involved in CD43-mediated apoptosis of TF-1 cells. Roles of transcription Daxx expression, and adhesion molecules. J Biol Chem 277: 7955-7961.
10. Deng J, Miller S, Wang H, Xia W, Wen Y, Zhou B et al. (2002). beta-Catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell 2: 323-334.
11. Dragone LL, Barth RK, Sitar KL, Disbrow GL, Frelinger JG. (1995). Disregulation of leukosialin (CD43, Ly48, sialophorin) expression in the B-cell lineage of transgenic mice increases splenic B-cell number and survival. Proc Natl Acad Sci USA 92: 626-630.
12. Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB et al. (2000). Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 60: 129-133.
13. Evan GI, Vousden KH. (2001). Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348.
14. Fearon E, Vogelstein B. (1990). A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
15. Fernandez-Rodriguez J, Andersson CX, Laos S, Baeckstrom D, Sikut A, Sikut R et al. (2002). The leukocyte antigen CD43 is expressed in different cell lines of nonhematopoietic origin. Tumour Biol 23: 193-201.
16. He YW, Bevan MJ. (1999). High level expression of CD43 inhibits T cell receptor/CD3-mediated apoptosis. J Exp Med 190: 1903-1908.
17. Hewitt RE, McMarlin A, Kleiner D, Wersto R, Martin P, Tsokos M et al. (2000). Validation of a model of colon cancer progression. J Pathol 192: 446-454.
18. Ivanov VN, Lopez Bergami P, Maulit G, Sato TA, Sassoon D, Ronai Z. (2003). FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface. Mol Cell Biol 23: 3623-3635.
19. Kadaja L, Laos S, Maimets T. (2004). Overexpression of leukocyte marker CD43 causes activation of the tumor suppressor proteins p53 and ARF. Oncogene 23: 2523-2530.
20. Kyoizumi S, Ohara T, Kusunoki Y, Hayashi T, Koyama K, Tsuyama N. (2004). Expression characteristics and stimulatory functions of CD43 in human CD4+ memory T cells: analysis using a monoclonal antibody to CD43 that has a novel lineage specificity. J Immunol 172: 7246-7253.
21. Laos S, Baeckstrom D, Hansson GC. (2006). Inhibition of NF-kappaB activation and chemokine expression by the leukocyte glycoprotein, CD43, in colon cancer cells. Int J Oncol 28: 695-704.
22. Layseca-Espinosa E, Pedraza-Alva G, Montiel JL, del Rio R, Fierro NA, Gonzalez-Amaro R et al. (2003). T cell aggregation induced through CD43: intracellular signals and inhibition by the immunomodulatory drug leflunomide. J Leukoc Biol 74: 1083-1093.
23. Levine AJ. (1997). p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
24. Lowe SW, Sherr CJ. (2003). Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 13: 77-83.
25. Mazars R, Pujol P, Maudelonde T, Jeanteur P, Theillet C. (1991). p53 mutations in ovarian cancer: a late event? Oncogene 6: 1685-1690.
26. Mattioli I, Dittrich-Breiholz O, Livingstone M, Kracht M, Schmitz ML. (2004). Comparative analysis of T-cell costimulation and CD43 activation reveals novel signaling pathways and target genes. Blood 104: 3302-3304.
27. Misawa Y, Nagaoka H, Kimoto H, Ishii Y, Kitamura K, Tsunetsugu-Yokota Y et al. (1996). CD43 expression in a B cell lymphoma, WEHI 231, reduces susceptibility to G1 arrest and extends survival in culture upon serum depletion. Eur J Immunol 26: 2573-2581.
28. Miura Y, Mizutani C, Nishihara T, Hishita T, Yanagi S, Tohyama Y et al. (2001). Adhesion via CD43 induces Syk activation and cell proliferation in TF-1 cells. Biochem Biophys Res Commun 288: 80-86.
29. Moller P, Koretz K, Leithauser F, Bruderlein S, Henne C, Quentmeier A et al. (1994). Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int J Cancer 57: 371-377.
30. Nagata S, Golstein P. (1995). The Fas death factor. Science 267: 1449-1456.
31. O'Connell J, Bennett MW, Nally K, Houston A, O'Sullivan GC, Shanahan F. (2000). Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict. Ann NY Acad Sci 910: 178-192; discussion 193-195.
32. Onami TM, Harrington LE, Williams MA, Galvan M, Larsen CP, Pearson TC et al. (2002). Dynamic regulation of T cell immunity by CD43. J Immunol 168: 6022-6031.
33. Ostberg JR, Barth RK, Frelinger JG. (1998). The Roman god Janus: a paradigm for the function of CD43. Immunol Today 19: 546-550.
34. Ouaaz F, Li M, Beg AA. (1999). A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immune-response genes and in Fas-induced cell death. J Exp Med 189: 999-1004.
35. Pallant A, Eskenazi A, Mattei MG, Fournier RE, Carlsson SR, Fukuda M et al. (1989). Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16. Proc Natl Acad Sci USA 86: 1328-1332.
36. Pimenidou A, Madden L, Topping K, Smith K, Monson J, Greenman J. (2004). Novel CD43 specific phage antibodies react with early stage colorectal tumours. Oncol Rep 11: 327-331.
37. Remold-O'Donnell E, Kenney DM, Parkman R, Cairns L, Savage B, Rosen FS. (1984). Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Exp Med 159: 1705-1723.
38. Rodrigues N, Rowan A, Smith M, Kerr I, Bodmer W, Gannon J et al. (1990). p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87: 7555-7559.
39. Santamaria M, Lopez-Beltran A, Toro M, Pena J, Molina IJ. (1996). Specific monoclonal antibodies against leukocyte-restricted cell surface molecule CD43 react with nonhematopoietic tumor cells. Cancer Res 56: 3526-3529.
40. Santana MA, Pedraza-Alva G, Olivares-Zavaleta N, Madrid-Marina V, Horejsi V, Burakoff SJ et al. (2000). CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, and NFkappa B transcription factors in human T lymphocytes. J Biol Chem 275: 31460-31468.
41. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ et al. (1998). Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675-1687.
42. Shelley CS, Remold-O'Donnell E, Davis III AE, Bruns GA, Rosen FS, Carroll MC et al. (1989). Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Proc Natl Acad Sci USA 86: 2819-2823.
43. Sherr CJ, Weber JD. (2000). The ARF/p53 pathway. Curr Opin Genet Dev 10: 94-99.
44. Sikut R, Andersson CX, Sikut A, Fernandez-Rodriguez J, Karlsson NG, Hansson GC. (1999). Detection of CD43 (leukosialin) in colon adenoma and adenocarcinoma by novel monoclonal antibodies against its intracellular domain. Int J Cancer 82: 52-58.
45. Sikut R, Nilsson O, Baeckstrom D, Hansson GC. (1997). Colon adenoma and cancer cells aberrantly express the leukocyte-associated sialoglycoprotein CD43. Biochem Biophys Res Commun 238: 612-616.
46. von Reyher U, Strater J, Kittstein W, Gschwendt M, Krammer PH, Moller P. (1998). Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res 58: 526-534.
47. Woodman RC, Johnston B, Hickey MJ, Teoh D, Reinhardt P, Poon BY et al. (1998). The functional paradox of CD43 in leukocyte recruitment: a study using CD43-deficient mice. J Exp Med 188: 2181-2186.
48. Zhang K, Sikut R, Hansson GC. (1997). A MUC1 mucin secreted from a colon carcinoma cell line inhibits target cell lysis by natural killer cells. Cell Immunol 176: 158-165.
49. Zheng Y, Ouaaz F, Bruzzo P, Singh V, Gerondakis S, Beg AA. (2001). NF-kappa B RelA (p65) is essential for TNF-alpha-induced Fas expression but dispensable for both TCR-induced expression and activation-induced cell death. J Immunol 166: 4949-4957.
50. Ziprin P, Alkhamesi NA, Ridgway PF, Peck DH, Darzi AW. (2004). Tumour-expressed CD43 (sialophorin) mediates tumourmesothelial cell adhesion. Biol Chem 385: 755-761.